MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aerie Pharmaceuticals Company Profile (NASDAQ:AERI)

Consensus Ratings for Aerie Pharmaceuticals (NASDAQ:AERI) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $40.63 (156.15% upside)

Analysts' Ratings History for Aerie Pharmaceuticals (NASDAQ:AERI)
Show:
DateFirmActionRatingPrice TargetActions
4/7/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2016Cantor FitzgeraldReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2016RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Canaccord GenuityReiterated RatingBuy$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2015JMP SecuritiesBoost Price TargetOutperform$39.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2015Needham & Company LLCBoost Price TargetBuy$27.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2015Stifel NicolausBoost Price TargetBuy$30.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Piper JaffrayReiterated RatingBuy$7.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/1/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha